Insider · CIK 0001171780
Edward J Rapp
director
Files at ABBV (AbbVie Inc.), XOS (Xos, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | ABBV AbbVie Inc. | AGrant or award Stock Equivalent Unitsderivative | +129 | $261.59 | $34k | 29,568 | 10 d ago |
| May 9, 2025 | ABBV AbbVie Inc. | AGrant or award Common Stock, $0.01 par value | +1,203 | $0.00 | $0 | 34,458 | May 13, 2025 |
| Mar 31, 2025 | ABBV AbbVie Inc. | AGrant or award Stock Equivalent Unitsderivative | +155 | $209.52 | $32k | 27,361 | Apr 2, 2025 |
| Dec 31, 2024 | ABBV AbbVie Inc. | AGrant or award Stock Equivalent Unitsderivative | +182 | $177.70 | $32k | 26,976 | Jan 3, 2025 |
| Oct 10, 2024 | XOS Xos, Inc. | AGrant or award Common Stock | +1,065 | $0.00 | $0 | 55,034 | Dec 17, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.